Chromatin immunoprecipitation and additional research revealed that this H3K27 acetylated NAMPT enhancer binds to the transcription factors MAX and c-MYC, which control its activity, and performs substantially better exclusively in cancer cells that are dependent on the salvage pathway. Here, MYC is linked to cancer.